Richard G. Ghalie

2021

In 2021, Richard G. Ghalie earned a total compensation of $1.1M as Chief Medical Officer at MEI Pharma.

Compensation breakdown

Non-Equity Incentive Plan$118,065
Option Awards$522,750
Salary$432,481
Stock Awards$69,800
Total$1,143,096

Ghalie received $522.8K in option awards, accounting for 46% of the total pay in 2021.

Ghalie also received $118.1K in non-equity incentive plan, $432.5K in salary and $69.8K in stock awards.

Rankings

In 2021, Richard G. Ghalie's compensation ranked 8,319th out of 12,415 executives tracked by ExecPay. In other words, Ghalie earned more than 33.0% of executives.

ClassificationRankingPercentile
All
8,319
out of 12,415
33rd
Division
Manufacturing
3,681
out of 5,505
33rd
Major group
Chemicals And Allied Products
1,635
out of 2,375
31st
Industry group
Drugs
1,454
out of 2,096
31st
Industry
Pharmaceutical Preparations
1,082
out of 1,546
30th
Source: SEC filing on October 28, 2021.

Ghalie's colleagues

We found four more compensation records of executives who worked with Richard G. Ghalie at MEI Pharma in 2021.

2021

Daniel Gold

MEI Pharma

Chief Executive Officer

2021

David Urso

MEI Pharma

Chief Operating Officer

2021

Brian Drazba

MEI Pharma

Chief Financial Officer

2021

Robert Mass

MEI Pharma

Chief Medical Officer

News

You may also like